0001567619-18-008189.txt : 20181218
0001567619-18-008189.hdr.sgml : 20181218
20181218134732
ACCESSION NUMBER: 0001567619-18-008189
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181217
FILED AS OF DATE: 20181218
DATE AS OF CHANGE: 20181218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murley Robert S
CENTRAL INDEX KEY: 0001523923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35811
FILM NUMBER: 181240060
MAIL ADDRESS:
STREET 1: 4025 S. RIVERPOINT PARKWAY
STREET 2: M/S CF-K815
CITY: PHOENIX
STATE: AZ
ZIP: 85040
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Insurance Innovations, Inc.
CENTRAL INDEX KEY: 0001561387
STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411]
IRS NUMBER: 461282634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15438 N. FLORIDA AVENUE
STREET 2: SUITE 201
CITY: TAMPA
STATE: FL
ZIP: 33613
BUSINESS PHONE: 813-397-1187
MAIL ADDRESS:
STREET 1: 15438 N. FLORIDA AVENUE
STREET 2: SUITE 201
CITY: TAMPA
STATE: FL
ZIP: 33613
4
1
doc1.xml
FORM 4
X0306
4
2018-12-17
0
0001561387
Health Insurance Innovations, Inc.
HIIQ
0001523923
Murley Robert S
C/O HEALTH INSURANCE INNOVATIONS, INC.
15438 NORTH FLORIDA AVENUE, SUITE 201
TAMPA
FL
33613
1
0
0
0
Class A Common Stock
2018-12-17
4
P
0
5000
30.85
A
5000
I
By Robert Murley Revocable Trust
Class A Common Stock
2018-12-17
4
P
0
1500
30.84
A
1500
I
By Murley Enterprises
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $30.67 to $31.10, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $30.74 to $31.05, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
/s/ Michael Hershberger, Attorney-in-Fact for Robert S. Murley
2018-12-18